[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337347-105":59,"doc-detail-337347-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","microbiome-as-a-biomarker-and-therapeutic-target-in-pancreatic-cancer-review","Microbiome as a biomarker and therapeutic target in pancreatic cancer - Review","","Studying the microbiome’s role in cancer development has become a major research focus, particularly for pancreatic cancer (PC). This review explains how gastrointestinal microbiota may contribute to PC through persistent inflammation, impaired antitumor immune surveillance, and altered tumor microenvironment cellular processes. Because current diagnostic markers remain limited, microbial composition is highlighted as a non-invasive biomarker for clinical screening and patient prognosis. Saliva, stool, and blood samples can be analyzed with 16S rRNA sequencing to assess bacterial abundance. The review also discusses evidence for prebiotics, probiotics, antibiotics, fecal microbial transplantation, and bacteriophage therapy, alongside emerging treatment strategies to prevent dysbiosis progression and improve PC therapies.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/microbiome-as-a-biomarker-and-therapeutic-target-in-pancreatic-cancer-review/337347/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/microbiome-as-a-biomarker-and-therapeutic-target-in-pancreatic-cancer-review/337347.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"How does the microbiome potentially contribute to pancreatic cancer pathogenesis?","Question",{"text":113,"@type":114},"The review proposes mechanisms including persistent inflammation from microbiota, impairment of antitumor immune surveillance, and altered cellular processes within the tumor microenvironment.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why are microbial composition and the microbiome considered promising diagnostic biomarkers for pancreatic cancer?",{"text":118,"@type":114},"Current diagnostic markers are limited, so microbial composition is presented as a non-invasive biomarker that may support clinical screening and guide prognosis.",{"name":120,"@type":111,"acceptedAnswer":121},"What methods are described for analyzing microbiome samples relevant to pancreatic cancer?",{"text":122,"@type":114},"Samples such as saliva, stool, and blood can be analyzed using 16S rRNA sequencing to determine the relative abundance of specific bacteria.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},337347,1790114841,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":26,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Pourali et al. BMC Microbiology (2024) 24:16 [https://doi.org/10.1186/s12866-023-03166-4](https://doi.org/10.1186/s12866-023-03166-4)  \nBMC Microbiology  \n REVIEW Open Access  \nMicrobiome as a biomarker and therapeutic   target in pancreatic cancer  \nGhazaleh Pourali 1†, Danial Kazemi2†, Amir Shayan Chadeganipour9†, Mahshid Arastonejad3, Sara Naghizadeh Kashani 1, Roozbeh Pourali4, Mina Maftooh 1, Hamed Akbarzade1, Hamid Fiuji5,  \nSeyed Mahdi Hassanian 1,5, Majid Ghayour‑Mobarhan1, Gordon A. Ferns6, Majid Khazaei 1,5 and Amir Avan1,7,8*  \nAbstract  \nStudying the effects of the microbiome on the development of different types of cancer has recently received increasing research attention. In this context, the microbial content of organs of the gastrointestinal tract has been proposed to play a potential role in the development of pancreatic cancer (PC) . Proposed mechanisms for the patho‑ genesis of PC include persistent inflammation caused by microbiota leading to an impairment of antitumor immune surveillance and altered cellular processes in the tumor microenvironment. The limited available diagnostic markers that can currently be used for screening suggest the importance of microbial composition as a non‑invasive bio‑ marker that can be used in clinical settings. Samples including saliva, stool, and blood can be analyzed by 16 s rRNA sequencing to determine the relative abundance of specific bacteria. Studies have shown the potentially beneficial effects of prebiotics, probiotics, antibiotics, fecal microbial transplantation, and bacteriophage therapy in altering microbial diversity, and subsequently improving treatment outcomes. In this review, we summarize the potential impact of the microbiome in the pathogenesis of PC, and the role these microorganisms might play as biomarkers in the diagnosis and determining the prognosis of patients. We also discuss novel treatment methods being used to minimize or prevent the progression of dysbiosis by modulating the microbial composition. Emerging evidence is supportive of applying these findings to improve current therapeutic strategies employed in the treatment of PC.  \nKeywords Microbiome, Pancreatic cancer, Biomarker, Treatment, Probiotics, Diagnosis, Prognosis  \n†Ghazaleh Pourali, Danial Kazemi and Amir Shayan Chadeganipour contributed equally to this work.  \n*Correspondence: Amir Avan[avana@mums.ac.ir](avana@mums.ac.ir)  \n1 Metabolic Syndrome Research Center, Mashhad University of Medical Sciences, Mashhad, Iran  \n2 Student Research Committee, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, Iran  \n3 Department of Human and Molecular Genetics, Virginia Commonwealth University, Richmond, VA, USA  \n4 Student Research Committee, Faculty of Veterinary Medicine, Ferdowsi University of Mashhad, Mashhad, Iran  \n5 Basic Sciences Research Institute, Mashhad University of Medical Sciences, Mashhad, Iran  \n6 Brighton & Sussex Medical School, Department of Medical Education, Falmer, Brighton, Sussex BN1 9PH, UK  \n7 College of Medicine, University ofWarith Al‑Anbiyaa, Karbala, Iraq  \n8 School of Mechanical, Medical and Process Engineering, Science and Engineering Faculty, Queensland University of Technology, 2 George St, Brisbane City, QLD 4000, Australia  \n9 School of Medicine, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, Iran  \n© The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence an","cbCaiaf5q1hwzQFm","https://ap.wps.com/l/cbCaiaf5q1hwzQFm","pdf",2838041,24,"English","# Abstract\n# Introduction\n## Pancreatic cancer burden and survival\n## Genetic drivers and tumor aggressiveness\n## Tumor microenvironment and microbiome relevance","[{\"question\":\"How does the microbiome potentially contribute to pancreatic cancer pathogenesis?\",\"answer\":\"The review proposes mechanisms including persistent inflammation from microbiota, impairment of antitumor immune surveillance, and altered cellular processes within the tumor microenvironment.\"},{\"question\":\"Why are microbial composition and the microbiome considered promising diagnostic biomarkers for pancreatic cancer?\",\"answer\":\"Current diagnostic markers are limited, so microbial composition is presented as a non-invasive biomarker that may support clinical screening and guide prognosis.\"},{\"question\":\"What methods are described for analyzing microbiome samples relevant to pancreatic cancer?\",\"answer\":\"Samples such as saliva, stool, and blood can be analyzed using 16S rRNA sequencing to determine the relative abundance of specific bacteria.\"}]","Microbiome as a biomarker and therapeutic target in pancreatic cancer - Review | PDF",1790018718,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/585db6ef0467131f6a273e56dba062de.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61b20b72cfe36fa60aa5fa0c399e9c52.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/03bb73888622461cf835f4438f4c2eb7.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b1b11bfe54d95633fa8a497b538b856.webp",980,1301]